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Successful communication is considered an essential component of the quality of care and safety of the patient 
with Amyotrophic Lateral Sclerosis (ALS). Recent technology has provided alternative communication systems, 
including the Eye-tracking technology, which enables interaction with others in the more advanced stages of the 
disease. The aim of the study is to investigate patients' difficulties in using the eye tracker, their problem in ob-
taining the device and the clinical complications resulting from it. A “snowball sampling” method study was 
conducted from April to September 2020 until sample saturation. The results of the study demonstrate the 
countless difficulties in obtaining the eye- tracker, with long waiting times, which are not followed by adequate 
training in its correct use. Among the consequences linked to the use of this device, the most frequent were nys-
tagmus (8.8%), onset of eyelid ptosis (16.2%) and the appearance of increased fatigue. 56.1% of the sample used 
the eye tracker to surf the Internet whereas 9.1% used it to write e-mails. Overall, the use of the eye tracker led 
to an improvement in overall quality of life (24%). In Conclusions, the Eye-tracking technology is a valuable de-
vice for Alternative Augmentative Communication (AAC) in ALS patients and can be used with good perfor-
mance, therefore the need for information, training and improvement on this topic is essential 
 




The incidence of Amyotrophic Lateral Sclerosis 
(ALS) is about 1-3 cases per 100,000 inhabit-
ants per year and the relationship between 
physical impairment and psychological condi-
tion is an important issue that involves a direct 
correlation between severity of depression and 
physical disability. In recent decades, the pro-
gress of biomedical technologies has led to 
great benefits in the field of healthcare, with the 
aim of improving the health of individuals and 
offering alternative solutions to traumas and 
various diseases. Among these, ALS patients 
have always used computer media, including 
computers, writing and digital language systems 
to communicate with the outside world. 
(Beukelman and Mirenda, 2014). Studies on the 
mental evaluation of ALS patients have report-
ed complaints such as depression, anxiety, loss 
of emotional control and alienation, as well as a 
high risk of suicide in the early stages of the 
disease (Cui et al., 2015). In the presence of this 
debilitating neurodegenerative disease, the 
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home environment becomes the core of life, 
where the need to communicate grows and alt-
hough the progression of language symptoms 
may vary from person to person, almost all 
people with ALS have severe communication 
disorders (Beukelman and Mirenda, 2014). The 
spread of Alternative Augmentative Communi-
cation (AAC) strategies has offered great possi-
bilities to improve the communicative effec-
tiveness of people with ALS, also improving 
their quality of life. There is a great technologi-
cal variety of eye-tracker, in computerized sys-
tems that are called "Eye-tracking technology". 
The concept of Eye-tracking refers to a series 
of technologies that allow the monitoring and 
recording of the way a person looks at a given 
scene or image, in which areas they focus their 
attention, for how long and what order is fol-
lowed in their visual exploration. Eye-tracking 
analyses, through a digital camera (eye-tracker), 
the movement of the eye and in particular the 
position of the pupil. These devices do not 
provide new possibilities for curing or improv-
ing the disease condition but can improve and 
increasing the efficiency of responses to some 
essential needs for autonomy: communicating, 
working, having fun, and spending free time, 
controlling the living environment.  The eye is 
usually 'illuminated' by an infrared light emitter 
that defines the contour of the pupil and cre-
ates a light reflection that is captured by the 
high-resolution camera. These reflections are 
then processed by special software to calculate 
the position of the gaze in relation to an object 
or a position on the computer display. Another 
feature is the ability to move the head during 
use. This is only important for those who can 
still move their head, but not at all for those 
who cannot. When evaluating instruments, 
much attention should be paid to the software, 
as the software represents the 'autonomy func-
tions' that the instrument is able to handle. Eye-
tracker-based systems also require a previous 
calibration process. This new technological 
availability represents a great opportunity to 
improve or compensate for those conditions of 
disadvantage due to disability. In addition to the 
still excessive cost of these devices, an aspect 
emerges that is little considered in the studies 
present in the literature: not all participants are 
suitable for these studies and the time required 
for calibration, the difficulty of analyzing and 
interpreting the results is highlighted as one of 
the most important barriers (Hassan Montero 
and Herrero Solana, 2007). The aim of the 
study is to investigate patients' difficulties in us-
ing the eye tracker, their problem in obtaining 
the device and the clinical complications result-
ing from it. 
 
2. Methods and design of the study 
 
An observational, cross-sectional, multicentre 
study was conducted between April and Sep-
tember 2020.  The study was carried out 
through the electronic dissemination of an 
online questionnaire, as it was considered an ef-
fective and inexpensive method to find a signif-
icant number of participants among ALS pa-
tients. The study was conducted nationwide, 
through conventional, non-probability sam-
pling. Each patient, contacted through two so-
cial networks (private facebook and instagram 
groups), could join the study through a link to 
the study. The questionnaire used for data col-
lection consists of two sections: the first section 
is aimed at collecting socio-demographic in-
formation from the patients (age, gender, mari-
tal status, educational qualification, profession 
held before the disease, region and municipality 
of origin, stage and onset of the disease, heredi-
ty, etiopathogenesis) the second section ex-
plores everything about the eye-tracker, both 
the benefits and risks that the use of this device 
can bring, how to use it and problems that have 
arisen. All sections of the questionnaire were 
computerised by using a pre-set form from the 
Google Drive platform. People affected by 
ALS, coming from the different Italian regions, 
who were older than 18 years and who use the 
eye-tracker for communication and who signed 
the informed consent were included. Patients 
who do not use the eye-tracker, who are young-
er than 18 years old and who have not signed 
the informed consent were excluded.  
    
3. Ethical considerations 
 
The ethical characteristics of the study were set 
out in the questionnaire presentation. Participa-
tion in the study, being free and voluntary, was 
considered as an expression of consensus. It 
was specified that participation was voluntary, 
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and that the participant could refuse to partici-




The 68 patients willing to participate in the sur-
vey were given an ad hoc online questionnaire 
(consisting of 21 multiple-choice questions) to 
obtain more detailed information on the satis-
faction and use of this specific aid and the 
QUEST (Quebec User evaluation of satisfac-
tion with Assistive Technology) (Demers et al., 
2000) to have a standardised reference on the 
degree of satisfaction with the product, the ser-
vice and the supply, support, and verification 
service. 
 
5. Social and demographic sample character-
istics 
 
The sample consisted of 68 patients affected by 
ALS with a prevalence of the male gender 
(76.5%; n=52) and an average age of 57.13 
years and DS= 11.729. The prevalence of the 
sample came from the Puglia Region (29.4%; 
n=20). The 42.6% (n=29.4) are graduated, and 
the 29.4% (n=20) are employed. 64.7% (n=44) 
are married, and the partner appears to mainly 
take care of them (60.3%; n=41). 82.4% (n 56) 
receive a pension, which is not enough to cover 
their care expenses (52.3%; n 34). 63.2% 
(n=43) move only their eyes (Table 1). 
 
Table. 1 Social-demographic data (n 
=68) 
N (%) 
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Is the pension sufficient to cover the 
costs of providing care needs? 
Fairly 
Slightly sufficient 








Depending on the stage of the 

















6. Communication system and the use of the 
eye tracker 
 
92.6% (n=63) were immediately in favor of us-
ing the eye-tracker. 51.5% (n=35) used other 
systems for accessing the PC prior to the eye-
tracker, of which 37.8% (n=14) were reported 
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to have used head-controlled mouse emulators, 
while 36.8% (n=25) used alphabetical commu-
nication tables as other systems for AAC. 
42.6% (n=29) became aware of the eye-tracker 
through their medical specialist (neurologist, 
physiatrist), whose requirements for the use of 
the eye-tracker were assessed (30.9%; n=21). 
The test for the use of the eye-tracker was car-
ried out both at home (45.6%; n=31) and in 
hospital (47.1%; n=32), and only one type of 
eye-tracker was used (73.5%; n=50). The pre-
scription was made by the NHS specialist doc-
tor (Neurologist, Otolaryngologist, Physiatrist) 
(55.9%; n=38), with long timescales (57.4%; 
n=37). 32.4% (n=22) had been using the eye-
tracker for 4-12 months. Only 5.9% (n=4) had 
such difficulties during training that they were 
unable to use it and 39.7% (n=27) were able to 
use it "always" or "quite a bit" after training 
(39.7%; n=27) without difficulty. The technical 
problems associated with the device that make 
it difficult to use are the need for continuous 
recalibration (33.8%; n=23). 69.1% (n=47) also 
use the eye-tracker for other purposes in addi-
tion to communication, for surfing the Internet 
(56.1%, n=37). Over the course of the day, 
36.8% (n=25) spent between 2 and 5 hours us-
ing the eye gaze eye-tracker, of which 36.8% 
(n=25) were in bed. Using the eye-tracker 
caused 41.2% (n=28) eye fatigue, but 30.9% 
(n=21) had no health problems that made its 
use necessary. Only 8.8% (n=6) were not at all 
satisfied; 41.2% (n=28) felt that the device had 
brought "enough" improvement in the overall 
quality of their lives. The 33.3% (n=19) would 
ask for a greater health comfort (Table 2). 
 
Table. 2 The Eye-tracking technol-
ogy use 
N (%) 
Were you immediately in favor of 







Before using the eye tracker, did you 
use other systems to access the PC? 
 
Yes 35 (51.5) 
No 33 (48.5) 
If yes, please indicate which ones:  
Membrane mouse emulators 
Scanning mouse emulators 
Head-controlled mouse emulators 
Computer voice command software 
On-screen keyboards 








No other systems used 37 (56.1) 
Have you used other systems for 
AAC (Alternative Augmentative 
Communication)? 
 
Portable alphabetic communicators 














Specialist doctor (neurologist, physiat-
rist) 









Who carried out the assessment of 
your requirements for the use of the 
eye tracker? 
 
Specialist outpatient clinic of your local 
health authority 
Specialist outpatient clinic of another 
health authority 
Specialist doctor 







In which setting was the eye tracker 
test carried out? 
 
At home 





Did you try only one type of eye-
tracker or more than one? 
 
Do not remember 
More than one 




Please indicate other models:  




















Who prescribed it?  
Territorial district director 
Dedicated outpatient specialist doctor 
NHS specialist (Neurologist, Otolaryn-
gologist, Physiatrist) 






What difficulties did you encounter 




Delivery of another type of device 





How long have you been using the  
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Did you find any difficulties in train-
ing to use it? 
 
Many difficulties 









How long did the training take?  
One day 







Can you use it easily?  
Fairly 
I still have some difficulties 
Yes, all the time 





Have you encountered technical 
problems with the device that make 
it difficult to use? 
 
Machine malfunction 
Need for continuous recalibration 






Are you satisfied with the way and 
speed with which you can com-











Can you use the eye pointer for pur-
poses other than communication? 
 
No 





If the answer is "yes" or "no, but I 
would like to" please specify: 
Environmental control 
Managing files such as photos, videos, 
films, books, documents 
Work, study, research 
Send text messages 













How many hours per day do you 
spend using the eye-tracker? 
Less than 2 hours 
Between 2 and 5 hours 
Between 5 and 10 hours 







What position do you assume when 
using the eye reacker? 








Has using the eye tracker caused 












From the beginning of the use of the 
eye pointer to the present day, what 
health problems make its use diffi-
cult? 
Redness and tearing 
Burning in the eyes 
Occurrence of increased fatigue 
Difficulty constructing words and re-
duced ocular mobility, which makes it 
difficult to optimize dwell time on the 
letters 
Onset of nystagmus (difficulty in keep-
ing one's gaze fixed) 
Onset of palpebral ptosis (lower upper 
eyelid) 



















Do you think that the device has led 
to an improvement in the overall 
quality of your life? 
Yes, very much 
Somewhat 
A little 


















If yes, please indicate type of re-
quest 
More assistance to relieve my wife 
More home cares 
More health comforts 
More care prepared for ALS 
More heart in the hands of caregivers 
More care supports 















The aim of the study was to investigate the pa-
tients' difficulties in using the eye-tracker, the 
problems in obtaining the device and the result-
ing clinical complications. The study shows a 
clear predominance of men over women. This 
is in accordance with literature, where the dis-
ease affects both sexes, with a slight prevalence 
of men (Trojsi et al., 2012) whereas there is an 
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equal frequency between the two sexes in fami-
ly forms (Mora and Chiò, 2010). The mean age 
of our study was 57.13 years, which is in line 
with other Italian studies (Borasio et al., 2005; 
Trojsi et al., 2012) in contrast to another Italian 
study in which the average age was over 65 
years old (Garzillo et al., 2015). Rarely are cases 
of juvenile ALS with onset under 20 years of 
age and in 5% more cases can be observed in 
the same family nucleus, often with autosomal 
dominant inheritance (familial ALS). The vari-
ous risk factors investigated in the various stud-
ies include cigarette smoking, mechanical trau-
ma, intense physical activity and sport, expo-
sure to toxic substances (pesticides, herbicides, 
some insecticides), heavy metals (mercury, lead, 
arsenic) and electromagnetic fields. Studies are 
therefore focusing on finding genetic factors 
that alter individual susceptibility to external 
stimuli and thus modify the risk of developing 
the disease. ("A. Gemelli" et al., 2016). ALS is 
an event that affects not only the patient, but 
also the whole family that is forced to face rela-
tional, social, and organisational discomfort dai-
ly. As highlighted by the study, it is often the 
partner who takes on the role of caregiver 
(58.9%; n=40). Numerous studies have investi-
gated the importance of the caregiving activity 
carried out by caregivers and the effects on the 
quality of life and psychophysical well-being 
generated by being constantly in contact with 
the invalidating disease of a family member or 
friend. One study in the literature investigated 
the caregiving needs of the caregiver of a pa-
tient with a severe disability, especially in the 
early stages of the caregiving role, and found 
that the caregiver felt a greater need for emo-
tional and social support, communication, and 
information. (Moroni et al., 2008). Patients suf-
fering from ALS need high-intensity health and 
social care, as well as environmental retrofitting, 
to first adapt their home to a person in a wheel-
chair or bedridden, and then to provide artifi-
cial ventilation. Having adequate economic re-
sources and space makes a difference in terms 
of opportunities for care and quality of life. 
These costs can be transformed into unequal 
opportunities for access to cure and to-care 
support, given that the number of hours of 
home care provided by the public system is of-
ten largely insufficient. (Bosco and Cappellato, 
2016). In fact, in the study it emerged that 
82.4% (n=56), expressed that they receive an 
invalidity pension, compared with 17.6% 
(n=12) who expressed that they do not receive 
it at all, and of that population who stated that 
they receive an invalidity pension, 47.1% 
(n=32) and 38.2% (n=26) complained that it is 
insufficient or even not sufficient to cover the 
expenses to guarantee the best possible care 
needs. In the second section, everything con-
cerning the eye-tracker was evaluated: benefits 
and risks that the use of such a device may pro-
vide, ways of using it and problems that have 
arisen. The possibility of using eye-tracking PC 
interface systems has offered a new possibility 
in enabling communication in subjects with se-
vere motor disabilities, such as those who are 
unable to communicate verbally in oral and 
written form. It is therefore essential to make 
use of the resources that the subject possesses, 
including eye movement, one of the few parts 
of the body that subjects can still control 
(63.2%; n=43), around which the eye-tracker 
technology was created, and which immediately 
received favourable opinions among the pa-
tients in this study (92.6%; n=63). The evalua-
tion of the requirements to use the eye-tracker 
was carried out by the specialist doctor of the 
local health authority (30.9%; n=21) as well as 
the prescription, data in line with another Ital-
ian study (Gasperini M.; 2010). The place where 
the test was carried out appears to be divided 
between hospital and home, unlike another Ital-
ian study in which home was the unanimous 
answer. Regarding the model of eye tracking 
device, only 22.1% (n=15) confirmed having 
used more than one. Each tracker has its own 
characteristics that should be evaluated based 
on factors such as the subject who is going to 
use it, the presence of a monocular/biocular 
tracker or one that allows access to other mul-
timedia systems. There are no eye-tracker that 
are better than others, but simply subjects with 
different needs. According to our data the most 
used eye-tracker is the Tobii Dynavox (4.4%; 
n=3) and the Eye Gaze (4.4%; n=3), while 
77.9% (n=53) of the sample did not answer. 
This could lead to the hypothesis that not all 
the subjects were made aware of the model 
with which the test was carried out, nor were 
they aware of other models with different char-
acteristics, which would perhaps be essential for 
that subject rather than another. Moreover, not 
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all the devices are equipped with automatic re-
calibration; in fact, the need for continuous re-
calibration appears among the technical prob-
lems related to the device that make its use dif-
ficult (33.8%; n=23). Despite the difficulties 
during training, 79.4% (n=54) once they have 
learnt how to use the ring eye-tracker, they are 
able to use it with ease, even for other purposes 
besides communication, such as surfing the In-
ternet (56.1%; n=37), but despite this 36.8% 
(n=25) state that they still use alternative sys-
tems for alternative augmentative communica-
tion, such as alphabetical communication ta-
bles. However, some typical eye movement 
problems such as nystagmus and strabismus, 
mydriasis or miosis and eyelid ptosis can inter-
fere with eye tracking. For this reason, some 
eye-tracker have correction filters to compen-
sate for these problems. To use this type of in-
strument, there must also be adequate ocular 
vision, i.e., the absence of objective eye prob-
lems such as double vision, cataracts, etc., the 
ability to maintain the position in front of the 
monitor, cognitive skills appropriate to the task, 
such as being able to read and memorise the 
procedures necessary to use the various func-
tions, and the motivation and interest of the us-
er (Gasperini et al. 2011).  The survey also as-
sessed the clinical complications encountered, 
considering the months of use, which vary 
from 1 month to >36 months. The complica-
tion found by most of the sample (41.2%; 
n=28) was fatigue, which can be related to the 
hours of daily use of the device, 2-5 hours for 
36.8% (25), and 5-10 for (29.4%; n=20) data in 
line with another Italian study (Gasperini et al. 
2011). Complications according to 21% are not 
such as to make their use difficult.  51.5% of 
the population were quite satisfied with the way 
and speed with which they were able to com-
municate their care needs and complex 
thoughts using the eye-tracker and 76.5% stated 
that the new eye-tracking technology had led to 
an improvement in the overall quality of their 
lives. 
 
8. Limits of the study 
 
The limitations of the study may be represented 
by possible selection bias and by a small sample 
not representative of the entire Italian popula-
tion affected by ALS. 
 
9. Conclusions and perspective 
 
The aim of the study was to investigate the pa-
tients' difficulties in using the eye pointer, the 
problems in obtaining the device and the result-
ing clinical problems. The results obtained, con-
firming previous studies in the literature, show 
how long waiting times are for obtaining the 
device and some difficulties in training its use. 
In addition, clinical complications arising from 
the use of the device, such as nystagmus, re-
duced ocular motility, eyelid ptosis, fatigue, 
redness, lacrimation, ocular dehydration, con-
junctivitis, and headaches. But the principal as-
pect that emerges is precisely how the ocular 
pointer has proved, in the end, capable of im-
proving the global quality of life of every ALS 
patient, making it possible to communicate all 
care needs and complex thoughts with the out-
side world. In front of these results, it is neces-
sary to reach an important conclusion: the eye-
tracking computer system is a valuable device 
for CAA in ALS patients and can be used with 
good performance, so the need for information, 
training and improvement on this issue is es-
sential. This will be an important step towards 
eliminating the difficulties encountered and 
therefore less stress and isolation for each indi-
vidual patient. This study highlighted very in-
teresting aspects about a patient population 
with an extreme need to communicate. There 
are very few studies in the literature on alterna-
tive communication, so it would be good to ex-
plore this aspect further in multi-center, pro-
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